Scott C. Neils - 15 Aug 2026 Form 4 Insider Report for Xtant Medical Holdings, Inc. (XTNT)

Reporting relationship: CFO and Assistant Secretary
Issuer ticker: XTNT
Reported as of: 15 Aug 2026
Net transaction value: $0
SEC form: 4
Accepted by SEC: 18 Aug 2026, 17:54:44 UTC
Prior SEC filing: 16 Jan 2026
Source filing: View source filing
Reporting owner signature: /s/ Amy Culbert, attorney-in-fact

Key filing fact

Scott C. Neils filed Form 4 for Xtant Medical Holdings, Inc. (XTNT) on 18 Aug 2026.

Key facts

This page summarizes Scott C. Neils's Form 4 filing for Xtant Medical Holdings, Inc. (XTNT).
2 reported transactions and 0 derivative rows are listed below.
Accepted by SEC: 18 Aug 2026, 17:54.

Change

Previous filing in this sequence was filed on 16 Jan 2026.
Current net transaction value: $0.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001902610 Primary reporting owner

Neils Scott C

Relationship: CFO and Assistant Secretary
Address: C/O XTANT MEDICAL HOLDINGS, INC., 664 CRUISER LANE, BELGRADE
Signature: /s/ Amy Culbert, attorney-in-fact
Signature date: 18 Aug 2026

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

XTNT transaction

Common Stock

Award

Transaction value
Shares: +400,000
Change %: +47%
Price: $0.000000^*
Shares after: 1,243,381
Date: 15 Aug 2026
Ownership: Direct
Footnotes: F1, F2

XTNT transaction

Common Stock

Tax liability

Transaction value
Shares: -28,155
Change %: -2.3%
Price: $0.3100^*
Shares after: 1,215,226
Date: 15 Aug 2026
Ownership: Direct
Footnotes: F2, F3

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 3 footnotes

Footnote F1

These shares will vest with respect to 100,000 shares on each of August 15, 2027, August 15, 2028, August 15, 2029, and August 15, 2030 pursuant to a deferred stock unit (DSU) award granted under the Xtant Medical Holdings, Inc. Amended and Restated 2023 Equity Incentive Plan, conditioned upon the Reporting Person remaining an employee of Xtant through the applicable vesting date. The settlement of the vested shares underlying the DSU award has been deferred and will occur at a later date pursuant to the terms of the DSU award agreement. Each DSU represents a contingent right to receive one share of the Issuer's common stock.

Footnote F2

Includes an aggregate of 869,878 shares issuable upon vesting and settlement of restricted stock unit awards or DSU awards granted under the Xtant Medical Holdings, Inc. Amended and Restated 2023 Equity Incentive Plan conditioned upon the Reporting Person remaining an employee of Xtant through the respective vesting dates.

Footnote F3

These shares were withheld by the Issuer to pay tax withholding obligations upon vesting and settlement of restricted stock unit awards.